[Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].
Hibi
Toshifumi
T
Ogata
Haruhiko
H
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000906:Antibodies / Q000627:therapeutic use; D017951:Antigen Presentation; D015551:Autoimmunity; D003093:Colitis, Ulcerative / Q000276:immunology* / Q000628:therapy*; D003106:Colon / Q000166:cytology; D003424:Crohn Disease / Q000276:immunology* / Q000628:therapy*; D016207:Cytokines / Q000276:immunology / Q000502:physiology; D004847:Epithelial Cells / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D019804:Mesalamine / Q000627:therapeutic use; D009000:Monocytes / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D016207:Cytokines; D007166:Immunosuppressive Agents; D019804:Mesalamine